Home » Authors » CenterWatch Staff

Articles by CenterWatch Staff

Antibacterial drugs market to top $45B globally in 2019

March 24, 2014

CenterWatch Staff

Sirtex, Guerbet collaborate on clinical studies in liver cancer

March 24, 2014

CenterWatch Staff

Orphan drug market expected to grow through 2018

March 24, 2014

CenterWatch Staff

Agios enrolls first patient in phase I study of AG-120

March 21, 2014

CenterWatch Staff

Accelrys Science Council adds three new fellows

March 21, 2014

CenterWatch Staff

Jeremiah McDole named director of Clinical R&D at StemGenex

March 21, 2014

CenterWatch Staff

Report: Patients expect sponsors to help them manage their health

March 21, 2014

CenterWatch Staff

Aptiv Solutions enables first surrogate endpoint-based adaptive clinical trials

March 21, 2014

CenterWatch Staff

FDA approves Impavido to treat tropical disease leishmaniasis

March 20, 2014

CenterWatch Staff

George A. Scangos to join Agilent Technologies board of directors

March 20, 2014

CenterWatch Staff

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here

Articles by CenterWatch Staff

Antibacterial drugs market to top $45B globally in 2019

Sirtex, Guerbet collaborate on clinical studies in liver cancer

Orphan drug market expected to grow through 2018

Agios enrolls first patient in phase I study of AG-120

Accelrys Science Council adds three new fellows

Jeremiah McDole named director of Clinical R&D at StemGenex

Report: Patients expect sponsors to help them manage their health

Aptiv Solutions enables first surrogate endpoint-based adaptive clinical trials

FDA approves Impavido to treat tropical disease leishmaniasis

George A. Scangos to join Agilent Technologies board of directors

Featured Products

Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Best Practices for Clinical Trial Site Management

Featured Stories

Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

Ask the Experts: Applying Quality by Design to Protocols

Clinical Trials Need Greater Representation of Obese Patients, Experts Say

FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.